Science & Enterprise subscription

Follow us on Twitter

  • An academic-industry collaboration is creating a non-invasive technique to detect rupture-prone plaque build-ups in… https://t.co/U6v6tBF4PA
    about 9 hours ago
  • New post on Science and Enterprise: Math Model to Gauge Heart Attack Risk from Plaques https://t.co/7BIPROFhpv #Science #Business
    about 9 hours ago
  • National Institutes of Health is supporting development of an extended-release probiotic treatment for necrotizing… https://t.co/d99utcSRV1
    about 2 days ago
  • New post on Science and Enterprise: Small Biz Grant Funds Pre-Term Gut Microbe Therapy https://t.co/f7WmGFYOuD #Science #Business
    about 2 days ago
  • A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from… https://t.co/t5QBG7wnwO
    about 2 days ago

Please share Science & Enterprise

Company Launches Attacking Cancer Proteins, Lands $67M

Cancer magnified

A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies. . . . → Read More: Company Launches Attacking Cancer Proteins, Lands $67M

Liquid Biopsy Screening Start-Up Launches, Gains $110M

Blood sample tubes

A new enterprise is starting up, developing early-stage cancer screening with a single blood test, based on research at Johns Hopkins University. . . . → Read More: Liquid Biopsy Screening Start-Up Launches, Gains $110M

Viral Disease Biotech Joins ElevateBio, Gains $120M

T-cells illustration

A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M

Start-Up to Use Stem Cells for Hearing Loss

Headphones

A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss. . . . → Read More: Start-Up to Use Stem Cells for Hearing Loss

Company Helps Labs Build Gene, Cell Therapy Businesses

DNAmolcule model

A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs. . . . → Read More: Company Helps Labs Build Gene, Cell Therapy Businesses

Infographic – Machine Learning Grabs Most A.I. Investments

A.I. investment chart

So far this year, machine learning applications and platforms are gaining the most investment dollars worldwide for A.I., this weekend’s infographic. . . . → Read More: Infographic – Machine Learning Grabs Most A.I. Investments

Companies Partner on Kidney Disease in $2B Deal

Goldfinch

A collaboration between biopharmaceutical maker Gilead Sciences and biotechnology company Goldfinch Bio aims to develop precision medicines for treating various kidney diseases. . . . → Read More: Companies Partner on Kidney Disease in $2B Deal

Start-Up to Use Crispr for Heart Disease, Gains $59M

Editing DNA

A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease. . . . → Read More: Start-Up to Use Crispr for Heart Disease, Gains $59M

Synthetic Soft Tissue Developed for Surgery

Surgery

Researchers developed a synthetic soft tissue for plastic and reconstructive surgery that in animal tests looks and performs more like real tissue. . . . → Read More: Synthetic Soft Tissue Developed for Surgery

Infographic – Venture Deals Cool Off in Q1 2019

Chart, venture funding by quarter

Venture capital investments worldwide declined in the first quarter of 2019, compared to the near record-setting pace of the last 3 months of 2018. . . . → Read More: Infographic – Venture Deals Cool Off in Q1 2019